ATP13A3 and pulmonary arterial hypertension: The PAH patients with or without ATP13A3 genetic variants are reported in Supplemental Table S4, which illustrates that there were higher mPAP values (52 ± 7 vs. 38 ± 13 mmHg, p = 0.043) in the ATP13A3 variant subgroup compared to the non-ATP13A3 variant carriers.